Sceptre Equity Growth
Over the past fifteen years the Sceptre
Equity Growth fund has gained an average of
12.1% annually, outperforming most smallcap
funds and the BMO Nesbitt-Burns Small-
Cap index, which returned, respectively,
10.4% and 8.2%. More recently, the fund
weathered the down market well posting
positive annual returns since 1999, the
weakest being a 1.7% gain in 2000.
Admittedly, this did lag the Small-Cap index
which gained 7.3% that year. On the other
hand 2003 was a banner year for the fund,
which posted a spectacular 66.7% gain. This
performance was followed by a more muted
5.6% gain for the first three quarters of this
year.
The fund is managed by Allan Jacobs,
who has been at the helm for eleven of the
fund's seventeen years. Mr. Jacobs, who
speaks passionately about stock picking,
focuses on small and mid-cap stocks with
between $150 million and $2 billion in market
capitalization. He uses a low-risk bottom-up
approach, selecting financially strong
companies that have exhibited long-term
profitability, good return on equity, and
strong earnings growth yet which trade at low
multiples. Mr. Jacobs also places strong
emphasis on skilled management, which he
considers essential for smaller companies.
Over time, the fund's stock selection style has
drifted from a value orientation to one that is
now closer to growth-at-a-reasonable-price
(GARP).
To maintain focus the fund generally
holds no more than about fifty stocks and
invests mainly in Canadian companies. Care
is taken to maintain adequate diversification
but no explicit sector targets are set, which is
in keeping with Mr. Jacobs' bottom-up
approach. Once a stock is purchased it stays
in the portfolio for as long as its fundamentals
remain attractive. The fund's average 44%
turnover suggests that this typically means a
period of about two years. Factors that will
trigger a sale include slowing earnings
growth, a market capitalization that has
grown such as to qualify the stock for the
large-cap label, and the appearance of better
stocks. Large price increases will also often
trigger some profit-taking.
The portfolio's fundamentals are, in
aggregate, similar to those of the S&P Small
Cap 600 index. Its earnings yield of 3.5% is
lower than the index's 4%, driven down in
part by a pair of biotech stocks. The dividend
yield of 0.7% is also a bit lower than the
index's 1% yield. On a price-to-book and
price-to-cash-flow basis the fund is
comparable to the index. From a value
perspective the portfolio is a bit expensive as
might be expected based on the fund's GARP
style.
At the end of September the fund held
fifty stocks, two trusts, and a 8.8% cash
position. The fund also held a small number
of warrants and subscription receipts. Metals
and Minerals was the top sector in the
portfolio, followed by Consumer Products
and Energy. The top holdings were Reitmans
Canada, Peyto Energy Trust, and Petro-
Kazakhstan, which together accounted for just
over 11% of assets. During the third quarter
the fund was fairly active buying six new
stocks and selling nine, including Cinram
International and CoolBrands International
which had both been strong long-term
performers for the fund. New purchases
included Canfor, Peru Copper (an IPO), and
Chap Mercantile, which has already climbed
100%.
The fund's fairly large cash position
during the past several quarters is not to be
interpreted as a negative outlook, according to
Mr. Jacobs. Rather, he attributes it to a recent
excess of trimming over buying. However, he
does admit to having become more cautious
in recent years, citing geopolitical concerns.
He adds that he does not intend to further
increase the fund's cash holdings. Mr. Jacobs
could not point to any single cause for worry,
discounting concerns about oil prices, interest
rates, and the rise of the Canadian dollar. He
prefers instead to focus on selecting good
stocks and harbours an almost contrarian
cynicism regarding projections.
When asked to choose a favorite recent
pick Mr. Jacobs pointed out that one-third of
current holdings have more than doubled in
price since they were purchased. Names
mentioned included Inmet Mining, Rona, and
Wheaton River Minerals. On the worst pick
side, he points to his first foray into biotech
stocks, which worked out well for a time.
However, both stocks have since dropped
significantly. He took his lumps in this case,
admitting that he failed to sell on bad news in
a sector that he now recognizes is very much
sentiment-driven.
For a $5,000 initial investment the
Sceptre Equity Growth fund is available
everywhere in Canada. Residents of Ontario,
BC, Manitoba, Saskatchewan, and New
Brunswick may purchase units directly from
Sceptre with no load, but those in other
provinces must go through a dealer or broker.
With a 1.72% MER, the Sceptre Equity
Growth fund offers a conservatively managed
portfolio and a superb record of performance
for a modest cost. It is a worthy candidate for
the small-cap portion of any well-balanced
portfolio. However, its somewhat high
volatility makes it most suitable for slightly
more aggressive frugal investors.
FF: Q3 2004
| |
|